Daxor Corporation Share Price & Technical Analysis

DXR · $10.82 (0.00%)

Healthcare / Medical Instruments & Supplies

AI Score 49 · Weak

$10.82

0.00%

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpor

Price chart

AI snapshotScore 49/100

Weak · Downtrend · Uptrend

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$58.53M

P/E ratio

6.12

52W high

$14.76

52W low

$7.73

Volume

158

Beta

0.29

Related stocks in Healthcare

Frequently asked questions

What is Daxor Corporation share price today?
Daxor Corporation (DXR) last traded around $10.82 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does DXR have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DXR. Download the app for real-time alerts.
How can I analyze Daxor Corporation stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro